ZIOPHARM ONCOLOGY INC (ZIOP) Stock Balance Sheet
NASDAQ:ZIOP - Nasdaq - Common Stock
| MRQ (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 91.72M | 115.10M | 79.70M | 61.70M | 70.90M | |||
| Receivables | 1.51M | 4.70M | 3.30M | 1.90M | 0.00 | |||
| Other Current Assets | 3.32M | 10.90M | 22.40M | 20.70M | 19.80M | |||
| Total Current Assets | 96.55M | 130.60M | 105.50M | 84.30M | 90.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 16.84M | 14.90M | 3.40M | 1.10M | 1.20M | |||
| Other Non-Current Assets | 367.00K | 900.00K | 200.00K | 9.70M | 13.60M | |||
| Total Non-Current Assets | 17.21M | 15.70M | 3.60M | 10.80M | 14.80M | |||
| TOTAL ASSETS | 113.76M | 146.30M | 109.10M | 95.10M | 105.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 12.04M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 14.67M | 17.40M | 11.60M | 8.80M | 9.90M | |||
| Accounts Payable | 1.46M | 1.00M | 900.00K | 700.00K | 4.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 6.50M | |||
| Total Current Liabilities | 28.17M | 18.40M | 12.50M | 9.50M | 20.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 12.17M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.71M | 4.00M | 1.60M | 0.00 | 37.60M | |||
| Total Non-Current Liabilities | 16.88M | 4.00M | 1.60M | 0.00 | 37.50M | |||
| TOTAL LIABILITIES | 45.05M | 22.40M | 14.10M | 9.50M | 58.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -831.06M | -764.10M | -684.10M | -566.30M | -712.40M | |||
| Additional Paid In Capital | 899.55M | 887.90M | 779.00M | 651.70M | 615.50M | |||
| Common Shares | 216.00K | 200.00K | 200.00K | 200.00K | 144.10M | |||
| Shares Outstanding | 216.15M | 214.60M | 181.80M | 161.10M | 142.70M | |||
| Tangible Book Value per Share | 0.32 | 0.58 | 0.52 | 0.53 | -0.68 | |||
| Total Shareholders' Equity | 68.71M | 124.00M | 95.00M | 85.60M | 47.20M | |||
| TOTAL LIABILITIES AND EQUITY | 113.76M | 146.30M | 109.10M | 95.10M | 105.60M | |||
| Statistics | ||||||||
| Debt/Equity | 0.18 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.43 | 7.10 | 8.44 | 8.87 | 4.34 | |||
| Return On Assets (ROA) | -78.87% | -54.67% | -107.97% | -55.86% | -51.44% | |||
| Return On Equity (ROE) | -130.59% | -64.50% | -124.00% | -62.06% | -115.08% | |||
All data in USD , ROIC based on taxRate of 0.21